Biosimilars in Medicare Part B: CMS Weighing Payment Demonstration To Boost Uptake

 
• By Cathy Kelly
  
Biosimilar Uptake Needs A Reimbursement Boost, OIG Concludes • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet